Showing results (1261-1270 of 5,058) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|October 11, 2020
Exploring the performance of outcome measures in MS for predicting cognitive and clinical progression in the following yearsAlfredo Damasceno, Luciana Ramalho Pimentel-Silva, Benito Pereira Damasceno, et al.
Multiple Sclerosis and Related Disorders|December 5, 2019
Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activityBrice T Cleland, Paula Papanek, Benjamin A Ingraham, et al.
Multiple Sclerosis and Related Disorders|November 22, 2022
Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitantsZsófia Kokas, Anett Járdánházy, Dániel Sandi, et al.
Multiple Sclerosis and Related Disorders|June 20, 2021
Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studiesBruce A C Cree, Ashish Pradhan, Jinglan Pei, et al.
Multiple Sclerosis and Related Disorders|June 20, 2021
Geographic heterogeneity in the association of varicella-zoster virus seropositivity and multiple sclerosis: A systematic review and meta-analysisErin M Rice, Smathorn Thakolwiboon, Mirla Avila
Multiple Sclerosis and Related Disorders|June 23, 2021
How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP)Kévin Bigaut, Mikaël Cohen, Françoise Durand-Dubief, et al.
Multiple Sclerosis and Related Disorders|June 23, 2021
Outcomes on Social and Classic Cognition in adults with Pediatric-onset Multiple SclerosisCatarina Massano, Marisa Lima, Isabel Monteiro, et al.
Multiple Sclerosis and Related Disorders|January 6, 2023
The increased perceived exertion during the six minute walking test is not accompanied by changes in cost of walking, gait characteristics or muscle fatigue in persons with multiple sclerosisKyra Theunissen, Guy Plasqui, Annelies Boonen, et al.
Multiple Sclerosis and Related Disorders|January 7, 2023
Estimated prevalence of AQP4 positive neuromyelitis optica spectrum disorder and MOG antibody associated disease in São Paulo, BrazilGuilherme Diogo Silva, Samira Luisa Apóstolos-Pereira, Dagoberto Callegaro
Multiple Sclerosis and Related Disorders|December 15, 2022
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging casesJorge Guzmán, Francisco Vera, Bernardita Soler, et al.
Pageof 506